Ear clip nerve stimulation for abnormal heartbeats from the lower heart chambers
Tests ear nerve stimulation against a sham in adults with ventricular arrhythmias.
Key facts
- Who runs it
- University College, London
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias
- Status
- Not yet recruiting
- People taking part
- 72 people, planned
- Started
- 15 Jun 2025
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- transcutaenous vagal nerve stimulation
- Sham transcutaenous vagal nerve stimulation
- Record updated
- 24 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with frequent extra heartbeats from the lower heart chambers (PVCs) or with repeated ventricular tachycardia (VT). It tests an ear-clip nerve stimulator against a sham device.
- Age
- Over 18 years (minimum age 18 Years).
- Sex
- All sexes can join.
- Disease stage
- PVC group: PVCs make up more than 10% of heartbeats over 24 hours on Holter monitoring. VT group: structural heart disease and at least three clinically significant VT events in the six months before joining.
- Earlier treatment
- VT group: must already have a transvenous implantable cardioverter defibrillator (ICD) in place.
Main reasons for not taking part
- PVC group: coronary artery disease, or heart failure or cardiomyopathy not caused by the PVCs.
- Known epilepsy (PVC group).
- VT group: NYHA stage IV heart failure, heart failure needing inotrope drugs or mechanical support, a heart attack or heart surgery in the last six months, or life expectancy under 12 months.
- Pregnant now or planning pregnancy in the next 12 months.
- Already using a TENS device for any reason.
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age > 18 years old
- Participants must understand and be willing to sign a written informed consent document
- PVC burden of >10% in a 24-hour period on Holter monitoring
- Participants with structural heart disease and a transvenous implantable cardioverter defibrillator (ICD) in situ
- At least three clinically significant VT events (VT events defined as either >30 seconds of sustained VT, appropriate ICD ATP therapies or appropriate ICD shocks) in the six months before enrolment
Who cannot take part
- Coronary artery disease
- Known cardiac disease (heart failure or cardiomyopathy) in the documented absence of PVCs. Individuals with suspected PVC-induced cardiomyopathy heart failure, defined as cardiomyopathy or heart failure only diagnosed in the setting of a >10% PVC burden, will be allowed to participate
- A known diagnosis of Epilepsy
- Heart failure syndrome with inotrope dependency or requiring mechanical assistance
- Reversible cause of arrhythmia (e.g. culprit electrolyte abnormality or toxin)
- NYHA (New York Heart Association) stage IV heart failure
- Myocardial infarction or cardiac surgery in the last six months
- Ongoing pregnancy or intention to become pregnant in the forthcoming 12 months
- Participants using a TENS device for any indication; VT cohort
- Life expectancy <12 months
- Ongoing pregnancy or intention to become pregnant in the forthcoming 12 months
- Participants using a TENS device for any indication
Other criteria
- PVC Cohort
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Ventricular arrhythmias are abnormal heart rhythms that arise from the bottom chambers of the heart. They can cause debilitating symptoms when they occur intermittently (these are called premature ventricular ectopics or PVCs) and can be life-threatening when they occur continuously (called ventricular tachycardia or VT). These are the most common causes of sudden cardiac death, especially in patients with pre-existing heart disease.
Read full original descriptionShow less
They can be a result of overactivation of the sympathetic nervous system, and in extreme circumstances, surgery to cut the nerve may be needed. A novel approach to target this nervous system using a transcutaneous electrical nerve stimulator (TENS) machine has successfully treated arrhythmias that come from the top chambers of the heart (atrial fibrillation). An ear clip is applied for an hour per day connected to a device (smaller than a phone) that can activate the parasympathetic nervous system (that counteracts the sympathetic nervous system). This is called Low-Level Tragus Stimulation (LLTS). Because it has been used for epilepsy for decades, we have evidence of a very high safety profile and tolerability. We plan to enrol 72 patients, 34 with many PVCs and 38 with VT, and randomise them to either first receive LLTS or first receive sham treatment (this will appear the same to the patient and researchers but without any meaningful vibrations being emitted in the sham group). Each patient will then swap over to the other treatment. We will compare whether the LLTS reduces the amount of ventricular arrhythmias during compared to the amount during the sham treatment period. We will use Holter monitors to measure the amount of PVCs after each period in the PVC group. VT patients have an implantable defibrillator that continuously monitors for VT episodes in this group. We will only enrol adults who can give informed consent, and study participation will not interfere with a patient's clinical treatment.
The 2 groups in the trial
- Active PhaseExisting treatment, for comparison
Treatment: transcutaenous vagal nerve stimulation
- Sham PhaseSham treatment, for comparison
Treatment: Sham transcutaenous vagal nerve stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcutaneous Electrical Vagus Nerve Stimulation for Suppression of Ventricular Arrhythmias
- Plain-language title
- Ear clip nerve stimulation for abnormal heartbeats from the lower heart chambersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 24 June 2025